RemeGen Co., Ltd. (9995.HK)

HKD 41.4

(8.8%)

Inventory Summary of RemeGen Co., Ltd.

RemeGen Co., Ltd.'s latest annual inventory in 2023 was 741.56 Million CNY , up 41.88% from previous year.
RemeGen Co., Ltd.'s latest quarterly inventory in 2024 Q2 was 740.65 Million CNY , down -1.44% from previous quarter.
RemeGen Co., Ltd. reported annual inventory of 522.67 Million CNY in 2022, up 86.46% from previous year.
RemeGen Co., Ltd. reported annual inventory of 280.31 Million CNY in 2021, up 323.41% from previous year.
RemeGen Co., Ltd. reported quarterly inventory of 740.65 Million CNY for 2024 Q2, down -1.44% from previous quarter.
RemeGen Co., Ltd. reported quarterly inventory of 708.46 Million CNY for 2023 Q2, up 13.48% from previous quarter.

Annual Inventory Chart of RemeGen Co., Ltd. (2023 - 2018)

Historical Annual Inventory of RemeGen Co., Ltd. (2023 - 2018)

Year	Inventory	Inventory Growth
2023	741.56 Million CNY	41.88%
2022	522.67 Million CNY	86.46%
2021	280.31 Million CNY	323.41%
2020	66.2 Million CNY	111.87%
2019	31.24 Million CNY	5.31%
2018	29.67 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q1	751.47 Million CNY	1.34%
2024 Q2	740.65 Million CNY	-1.44%
2023 Q2	708.46 Million CNY	13.48%
2023 FY	741.56 Million CNY	41.88%
2023 Q1	624.31 Million CNY	19.45%
2023 Q4	741.56 Million CNY	3.52%
2023 Q3	716.31 Million CNY	1.11%
2022 Q2	362.41 Million CNY	17.98%
2022 FY	522.67 Million CNY	86.46%
2022 Q4	522.67 Million CNY	18.18%
2022 Q3	442.28 Million CNY	22.04%
2022 Q1	307.19 Million CNY	9.59%
2021 FY	280.31 Million CNY	323.41%
2021 Q2	110.21 Million CNY	0.0%
2021 Q1	- CNY	-100.0%
2021 Q4	280.31 Million CNY	0.0%
2020 Q2	40.2 Million CNY	20.75%
2020 FY	66.2 Million CNY	111.87%
2020 Q4	66.2 Million CNY	0.0%
2020 Q3	66.2 Million CNY	64.67%
2020 Q1	33.29 Million CNY	6.56%
2019 Q3	31.24 Million CNY	0.0%
2019 FY	31.24 Million CNY	5.31%
2019 Q4	31.24 Million CNY	0.0%
2018 FY	29.67 Million CNY	0.0%

Peer Inventory Comparison of RemeGen Co., Ltd.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-1937.701%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	38.436%